An HIV-1 PR/RT genotyping assay for antiretroviral susceptibility workflows covering protease inhibitors and reverse-transcriptase inhibitor drug classes.
The PR/RT assay combines target-specific PCR reagents with HIV analysis software and is positioned for laboratories using either Sanger or next-generation sequencing platforms.
| Product | Reference |
|---|---|
| DeepChek Assay Protease / Reverse Transcriptase Genotyping and Drug Resistance (CE-IVD) | 121A24 |
| DeepChek Assay Protease / Reverse Transcriptase Genotyping and Drug Resistance (RUO) | 101B24 |
| DeepChek HIV Software (CE-IVD) | S-12-023 (HL) |
| ViroScore-HIV Annual Software License (CE-IVD) | S-09-014 |
A strong fit for laboratories focused on the most established HIV-1 PR/RT drug resistance regions.
Back To HIV Portfolio